Liquid
crystalline (LC) materials and their nonmedical applications
have been known for decades, especially in the production of displays;
however, the pharmaceutical implications of the LC state are inadequately
appreciated, and the misunderstanding of experimental data is leading
to possible errors, especially in relation to the physical stability
of medicines. The aim of this work was to study LC phases of itraconazole
(ITZ), an azole antifungal active molecule, and for the first time,
to generate full thermodynamic phase diagrams for ITZ/polymer systems,
taking into account isotropic and anisotropic phases that this drug
can form. It was found that supercooled ITZ does not form an amorphous
but a vitrified smectic (vSm) phase with a glass transition temperature
of 59.35 °C (determined using a 10 °C/min heating rate),
as is evident from X-ray diffraction and thermomicroscopic (PLM) experiments.
Two endothermic LC events with the onset temperature values for a
smectic to nematic transition of 73.2 ± 0.4 °C and a nematic
to isotropic transformation at 90.4 ± 0.35 °C and enthalpies
of transition of 416 ± 34 J/mol and 842 ± 10 J/mol, respectively,
were recorded. For the binary supercooled mixtures, PLM and differential
scanning calorimetry showed a phase separation with birefringent vSm
persistent over a wide polymer range, as noticed especially for the
hypromellose acetate succinate (HAS) systems. Both, smectic and nematic,
phases were detected for the supercooled ITZ/HAS and ITZ/methacrylic
acid–ethyl acrylate copolymer (EUD) mixtures, while geometric
restrictions inhibited the smectic formation in the ITZ/poly(acrylic
acid) (CAR) systems. The Flory–Huggins lattice theory coupled
with the Maier–Saupe–McMillan approach to model anisotropic
ordering of molecules was successfully utilized to create phase diagrams
for all ITZ/polymer mixtures. It was concluded that in a supercooled
ITR/polymer mix, if ITZ is present in a LC phase, immiscibility as
a result of molecule anisotropy is afforded. This study shows that
the LC nature of ITZ cannot be disregarded when designing stable formulations
containing this molecule.